SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited Second Quarter 2019 Financial Results BEIJING, China, August 15, 2019 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the secon]

By | 2019-08-17T03:34:48+00:00 August 16th, 2019|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Second Quarter 2019 Financial Results

[Sinovac Reports Unaudited Second Quarter 2019 Financial Results BEIJING, China, August 15, 2019 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the secon]

By | 2019-08-17T03:34:56+00:00 August 16th, 2019|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited Second Quarter 2019 Financial Results BEIJING, China, August 15, 2019 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the secon]

By | 2019-08-16T12:26:47+00:00 August 16th, 2019|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Second Quarter 2019 Financial Results

[Sinovac Reports Unaudited Second Quarter 2019 Financial Results BEIJING, China, August 15, 2019 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the secon]

By | 2019-08-16T12:26:53+00:00 August 16th, 2019|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMA] 10-Q: (Original Filing)

[] [LOAN AGREEMENT Party A: Zhilin Li ID Number: [XXX] Party B: Hainan Helpson Medical & Biotechnology Co., Ltd. The two parties above have reached the following agreements with regards to a loan based on equality, voluntariness and consensus. 1. Party A agrees to lend Party B a loan of RMB¥4.77 mill]

By | 2019-08-15T03:48:23+00:00 August 14th, 2019|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMA] 10-Q:

[] [LOAN AGREEMENT Party A: Zhilin Li ID Number: [XXX] Party B: Hainan Helpson Medical & Biotechnology Co., Ltd. The two parties above have reached the following agreements with regards to a loan based on equality, voluntariness and consensus. 1. Party A agrees to lend Party B a loan of RMB¥4.77 mill]

By | 2019-08-15T03:48:29+00:00 August 14th, 2019|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited First Quarter 2019 Financial Results BEIJING, China, July 10, 2019 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the first quart]

By | 2019-07-12T03:31:27+00:00 July 11th, 2019|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited First Quarter 2019 Financial Results

[Sinovac Reports Unaudited First Quarter 2019 Financial Results BEIJING, China, July 10, 2019 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the first quart]

By | 2019-07-12T03:31:31+00:00 July 11th, 2019|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar